Search

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Trial Phase 1 Recruiting March 15, 2026

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Trial N/A Recruiting March 15, 2026

Terazosin And Metabolic Energetics in Parkinson's Disease

Trial Phase 2 Not yet recruiting March 15, 2026

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Trial Phase 2 Completed March 15, 2026

UB-312 in Patients With Synucleinopathies

Trial Phase 1 Completed March 15, 2026

Paraquat induces neuroinflammation through glycolytic reprogramming in microglia: evidence from network toxicology analysis and in vitro experiments.

Research Chemico-biological interactions March 14, 2026

New insights into synaptic vesicle dysfunction in Parkinson's disease

News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents March 13, 2026

Genotype-associated outcomes after deep brain stimulation in Parkinson's disease: a systematic review, meta-analysis and epigenetic implications.

Research Neurologia i neurochirurgia polska March 13, 2026

Putamen dopamine synthesis, vesicular storage, and metabolism in Parkinson disease.

Research medRxiv : the preprint server for health sciences March 13, 2026

Effects of daily walking exercise on constipation in patients with Parkinson's disease.

Research BMJ open sport & exercise medicine March 13, 2026

Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease

Trial Phase 2 Completed March 12, 2026

Montelukast in Parkinson Disease

Trial Phase 2 Recruiting March 12, 2026

Allopregnanolone as a Regenerative Treatment for Parkinson's Disease

Trial Phase 1 Completed March 12, 2026

Parkinson's Disease Biomarker Study

Trial N/A Completed March 12, 2026

Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

Trial Phase 2 Not yet recruiting March 12, 2026

Exercise to Improve Sleep in Parkinson's Disease

Trial N/A Recruiting March 12, 2026

Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease

Trial Phase 4 Terminated March 12, 2026

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Trial Phase 1 Active, not recruiting March 12, 2026

Shake It ’til We Make It 2026

News Brian Grant Foundation March 12, 2026

The Effects of Digital Health Interventions on Motor Symptoms, Nonmotor Symptoms, and Quality of Life in Patients With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Research Journal of medical Internet research March 12, 2026